Innovent Biologics Inc

Common Name
Innovent Biologics
Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
5,659
Ticker
1801
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
Innovent Biologics Inc. engages in the research, development, manufacture, and sale of biologic therapies, primarily focusing on oncology, autoimmune, metabolic, and other major diseases. As a pharmac...

Innovent Biologics's GHG Emissions Data Preview

In 2023, Innovent Biologics completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources), and Scope 2 (indirect emissions from purchased energy).

However, Innovent Biologics has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2024202320222021 - 2017
Total Scope 1
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Unspecified Calculation Method
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000

This table provides a simplified preview of selected GHG emissions data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.

Insights into Innovent Biologics's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of Innovent Biologics amounted to 15,894.42 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).

Compared to 2022, the total operational greenhouse gas (GHG) emissions of Innovent Biologics decreased by 28.73%, showing that the company has made progress in taking action to reduce the climate impact of its operations.

Innovent Biologics's Scope 1 Emissions Over Time

20222023020406080tCO2e-2%
  • Total Scope 1
  • Year-over-Year Change

What are Innovent Biologics's Scope 1 emissions?

In 2023, the total Scope 1 emissions of Innovent Biologics were 65.17 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).

Compared to the previous year (2022), Innovent Biologics's Scope 1 emissions decreased by 2.35%, highlighting the company's efforts to lower direct emissions from assets it owns or controls.

What are Innovent Biologics's Scope 2 emissions?

In 2023, Innovent Biologics reported Scope 2 greenhouse gas (GHG) emissions of 15,829.25 tCOâ‚‚e without specifying the calculation method.

Has Innovent Biologics reduced its Scope 2 emissions over time?

Compared to the previous year (2022), Innovent Biologics's Scope 2 emissions (Unspecified Calculation Method) fell by 28.81% in 2023, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption.

What methodology does Innovent Biologics use for Scope 2 reporting?

In 2023, Innovent Biologics reported its Scope 2 emissions using an unspecified methodology.

Innovent Biologics's Scope 2 Emissions Over Time

2022202306 k12 k18 k24 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)